CBD-Rich Cannabis Extract Reduced Behavioral Problems in Children with Severe Autism

In a prospective study of 16 patients with severe autism treated with CBD-rich extract and 17 untreated controls with moderate autism, the CBD group showed significant reduction in maladaptive internalizing behaviors on the Vineland 3 scale (p=0.008) after three months. Caregivers of the CBD group also showed significant improvements in interpersonal sensitivity (p=0.038), global severity (p=0.025), and positive symptom distress (p=0.007) on the Brief Symptom Inventory.

Prospective, non-randomized observational study comparing 16 ASD patients receiving CBD-rich extract to 17 untreated controls. Assessments at baseline and 3 months using ATEC, CARS, Vineland 3 (patients) and BSI (caregivers).

Treatment options for behavioral symptoms of autism remain limited. The dual finding of patient improvement and caregiver mental health benefits suggests that effective ASD treatment creates a positive cascade for the entire family.

CBD for autism is an active area of research with growing parental interest and limited clinical data. This study adds to a small body of evidence suggesting potential benefits, particularly for anxiety and behavioral symptoms.

Non-randomized design with groups differing in baseline severity (severe vs moderate ASD). Very small sample size. No blinding. Three-month follow-up may be insufficient. Caregiver mental health improvements could reflect placebo effect or hope from trying a new treatment.